Molbio Diagnostics shares surged 16% on Thursday to Rs 1,456 apiece on the NSE, extending gains for a second straight session and taking the stock’s rally to nearly 30% in two days.
The stock has now climbed around 80% from its IPO price of Rs 810, after making a strong market debut in August with a 21% premium at Rs 980.